They both carry list prices of over $1,000 per month ... Wegovy and Zepbound belong to a class of drugs known as GLP-1 receptor agonists originally developed for type 2 diabetes. There has been ...

The Danish healthcare company is a leader in the anti-obesity market. While there will no doubt be plenty of competing GLP-1 drugs and weight loss products in the market in the future, Novo Nordisk ...